Receive our newsletter – data, insights and analysis delivered to you
  1. Adare Pharmaceuticals
15 February 2010

Eurand Issued US Patent for ZENPEP (pancrelipase) Delayed-Release Capsules

Eurand, a global specialty pharmaceutical company, announced today the grant of US Patent No. 7,658,918, titled ‘Stable digestive enzyme compositions’, by the United States Patent and Trademark Office (USPTO). The patent will provide Eurand with coverage until at least 20 February 2028 on ZENPEP® (pancrelipase) delayed-release capsules.

In 2009, the US Food and Drug Administration (FDA) granted ZENPEP five years of marketing exclusivity as a new chemical entity.

Dysphagia can affect many people throughout their lifetime and may compromise medication adherence.
For pharmaceutical manufacturers and healthcare providers, non-adherence to medication is a significant concern.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU